BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6339361)

  • 1. The classification of rheumatic diseases: impact of developments in immunoassays and immunogenetics.
    Kunkel HG
    Hum Pathol; 1983 Apr; 14(4):288-9. PubMed ID: 6339361
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies and their relation to rheumatic diseases.
    McCarty GA
    Med Clin North Am; 1986 Mar; 70(2):237-61. PubMed ID: 2419715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of antibodies to Sm (Smith) and RNP (ribonucleoprotein) in patients with rheumatic diseases.
    Tsay GJ; Su CB; Chen TY; Lin CS
    Taiwan Yi Xue Hui Za Zhi; 1984 May; 83(5):436-43. PubMed ID: 6332172
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance.
    Moutsopoulos HM; Giotaki H; Maddison PJ; Mavridis AC; Drosos AA; Skopouli FN
    Ann Rheum Dis; 1984 Apr; 43(2):285-7. PubMed ID: 6608925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen.
    Fritzler MJ; McCarty GA; Ryan JP; Kinsella TD
    Arthritis Rheum; 1983 Feb; 26(2):140-5. PubMed ID: 6600614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiple sample immunoblotting system (MSIS) for the intrinsic detection of antinuclear autoantibodies.
    Navarro E; Bach M; Durán N; Puigdomènech P; Palau J
    J Immunol Methods; 1986 Jul; 91(1):75-81. PubMed ID: 3522747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different methods for the detection of autoantibodies in autoimmune diseases.
    Grigolo B; Mazzetti I; Borzi RM; Meliconi R; Origgi L; Scorza R; Facchini A
    Int J Clin Lab Res; 1995; 25(4):205-10. PubMed ID: 8788549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen.
    Treadwell EL; Alspaugh MA; Wolfe JF; Sharp GC
    J Rheumatol; 1984 Oct; 11(5):658-62. PubMed ID: 6334745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to nonhistone nuclear antigens and their clinical significance.
    Nakamura RM; Tan EM
    Hum Pathol; 1983 May; 14(5):392-400. PubMed ID: 6341205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases.
    Rahman A; Stollar BD
    Lupus; 2008 Mar; 17(3):232-5. PubMed ID: 18372367
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arthritis in definitive systemic lupus erythematosus].
    Haberhauer G
    Z Arztl Fortbild (Jena); 1990; 84(3):85-7. PubMed ID: 2343605
    [No Abstract]   [Full Text] [Related]  

  • 12. Antinuclear antibodies in autoimmune disease. Significance and pathogenicity.
    Harmon CE
    Med Clin North Am; 1985 May; 69(3):547-63. PubMed ID: 3892191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against protein factors of the nuclear RNA processing apparatus.
    Sperling R
    Isr J Med Sci; 1992 Feb; 28(2):120-3. PubMed ID: 1559796
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical lupus with special reference to ANA negative lupus and lupus subsets.
    Hughes GR; Asherson RA
    Adv Nephrol Necker Hosp; 1985; 14():333-46. PubMed ID: 3919537
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.
    Smolen JS; Hassfeld W; Graninger W; Steiner G
    Clin Exp Rheumatol; 1990; 8 Suppl 5():41-4. PubMed ID: 2245525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus.
    Fisher DE; Reeves WH; Wisniewolski R; Lahita RG; Chiorazzi N
    Arthritis Rheum; 1985 Dec; 28(12):1348-55. PubMed ID: 2417607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel insights into systemic autoimmune rheumatic diseases using shared molecular signatures and an integrative analysis.
    Hudson M; Bernatsky S; Colmegna I; Lora M; Pastinen T; Klein Oros K; Greenwood CMT
    Epigenetics; 2017 Jun; 12(6):433-440. PubMed ID: 28387599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammatory rheumatism within the framework of autoimmune diseases].
    Van Slype J
    J Belge Rhumatol Med Phys; 1967; 22(4):204-7. PubMed ID: 4185872
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.
    Albon S; Bunn C; Swana G; Karim Y
    J Immunol Methods; 2011 Feb; 365(1-2):126-31. PubMed ID: 21184759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.